NM_006231.4:c.776G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006231.4(POLE):​c.776G>A​(p.Arg259His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0094 in 1,613,816 control chromosomes in the GnomAD database, including 97 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R259L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0059 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0098 ( 96 hom. )

Consequence

POLE
NM_006231.4 missense

Scores

1
5
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:23

Conservation

PhyloP100: 7.87

Publications

9 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005420238).
BP6
Variant 12-132677388-C-T is Benign according to our data. Variant chr12-132677388-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 221085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00588 (895/152208) while in subpopulation NFE AF = 0.0102 (696/68010). AF 95% confidence interval is 0.0096. There are 1 homozygotes in GnomAd4. There are 414 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 96 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.776G>Ap.Arg259His
missense
Exon 8 of 49NP_006222.2Q07864

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.776G>Ap.Arg259His
missense
Exon 8 of 49ENSP00000322570.5Q07864
POLE
ENST00000535270.5
TSL:1
c.695G>Ap.Arg232His
missense
Exon 7 of 48ENSP00000445753.1F5H1D6
POLE
ENST00000537064.5
TSL:1
n.776G>A
non_coding_transcript_exon
Exon 8 of 49ENSP00000442578.1F5H7E4

Frequencies

GnomAD3 genomes
AF:
0.00588
AC:
895
AN:
152090
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00227
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.00347
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00273
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0102
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00522
AC:
1312
AN:
251450
AF XY:
0.00514
show subpopulations
Gnomad AFR exome
AF:
0.00209
Gnomad AMR exome
AF:
0.00237
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000435
Gnomad FIN exome
AF:
0.00319
Gnomad NFE exome
AF:
0.00943
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00977
AC:
14276
AN:
1461608
Hom.:
96
Cov.:
31
AF XY:
0.00940
AC XY:
6834
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.00203
AC:
68
AN:
33480
American (AMR)
AF:
0.00284
AC:
127
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39698
South Asian (SAS)
AF:
0.000417
AC:
36
AN:
86254
European-Finnish (FIN)
AF:
0.00300
AC:
160
AN:
53394
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0120
AC:
13371
AN:
1111764
Other (OTH)
AF:
0.00836
AC:
505
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
661
1322
1984
2645
3306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00588
AC:
895
AN:
152208
Hom.:
1
Cov.:
32
AF XY:
0.00556
AC XY:
414
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00227
AC:
94
AN:
41500
American (AMR)
AF:
0.00347
AC:
53
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00273
AC:
29
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0102
AC:
696
AN:
68010
Other (OTH)
AF:
0.00522
AC:
11
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
42
85
127
170
212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00822
Hom.:
16
Bravo
AF:
0.00574
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0132
AC:
51
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0101
AC:
87
ExAC
AF:
0.00529
AC:
642
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0104
EpiControl
AF:
0.00954

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
11
not provided (11)
-
-
5
not specified (5)
-
-
3
Colorectal cancer, susceptibility to, 12 (3)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
1
Carcinoma of colon (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.18
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T
Eigen
Uncertain
0.24
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D
MetaRNN
Benign
0.0054
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
7.9
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.14
Sift
Benign
0.20
T
Sift4G
Benign
0.23
T
Polyphen
0.13
B
Vest4
0.59
MVP
0.33
MPC
0.27
ClinPred
0.020
T
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.51
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61732929; hg19: chr12-133253974; COSMIC: COSV57692192; COSMIC: COSV57692192; API